{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T20:31:40Z","timestamp":1676925100670},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T00:00:00Z","timestamp":1379376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s12185-013-1430-9","type":"journal-article","created":{"date-parts":[[2013,9,16]],"date-time":"2013-09-16T08:59:27Z","timestamp":1379321967000},"page":"463-471","source":"Crossref","is-referenced-by-count":4,"title":["Clinical outcomes of allogeneic stem cell transplantation for relapsed or refractory follicular lymphoma: a retrospective analysis by the Fukuoka Blood and Marrow Transplantation Group"],"prefix":"10.1007","volume":"98","author":[{"given":"Yoshikiyo","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Takase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideho","family":"Henzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Sugio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuju","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Eto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,17]]},"reference":[{"key":"1430_CR1","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.1986.4.10.1470","volume":"4","author":"CJ Gallagher","year":"1986","unstructured":"Gallagher CJ, Gregory WM, Jones AE, Stansfeld AG, Richards MA, Dhaliwal HS, et al. Follicular lymphoma: prognostic factors for response and survival. J Clin Oncol. 1986;4:1470\u201380.","journal-title":"J Clin Oncol"},{"key":"1430_CR2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1200\/JCO.1995.13.1.140","volume":"13","author":"PW Johnson","year":"1995","unstructured":"Johnson PW, Rohatiner AZ, Whelan JS, Price CG, Love S, Lim J, et al. Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J Clin Oncol. 1995;13:140\u20137.","journal-title":"J Clin Oncol"},{"key":"1430_CR3","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood-2002-02-0506","volume":"100","author":"DI Marks","year":"2002","unstructured":"Marks DI, Lush R, Cavenagh J, Milligan DW, Schey S, Parker A, et al. The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation. Blood. 2002;100:3108\u201314.","journal-title":"Blood"},{"key":"1430_CR4","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/sj.bmt.1704290","volume":"32","author":"CM Mandigers","year":"2003","unstructured":"Mandigers CM, Verdonck LF, Meijerink JP, Dekker AW, Schattenberg AV, Raemaekers JM. Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation. Bone Marrow Transplant. 2003;32:1159\u201363.","journal-title":"Bone Marrow Transplant"},{"key":"1430_CR5","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood.V98.13.3595","volume":"98","author":"IF Khouri","year":"2001","unstructured":"Khouri IF, Saliba RM, Giralt SA, Lee MS, Okoroji GJ, Hagemeister FB, et al. Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality. Blood. 2001;98:3595\u20139.","journal-title":"Blood"},{"key":"1430_CR6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bbmt.2010.11.004","volume":"17","author":"MR Tomblyn","year":"2011","unstructured":"Tomblyn MR, Ewell M, Bredeson C, Kahl BS, Goodman SA, Horowitz MM, et al. Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response. Biol Blood Marrow Transplant. 2011;17:1051\u20137.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1430_CR7","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/bmt.2012.10","volume":"47","author":"N Reddy","year":"2012","unstructured":"Reddy N, Greer JP, Goodman S, Engelhardt B, Oluwole O, Jagasia MH, et al. Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma. Bone Marrow Transplant. 2012;47:1318\u201320.","journal-title":"Bone Marrow Transplant"},{"key":"1430_CR8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ajh.23261","volume":"87","author":"Y Ono","year":"2012","unstructured":"Ono Y, Mori T, Kato J, Yamane A, Shimizu T, Kikuchi T, et al. Long-term follow-up of reduced-intensity allogeneic hematopoietic stem cell transplantation for refractory or relapsed follicular lymphoma. Am J Hematol. 2012;87:929\u201331.","journal-title":"Am J Hematol"},{"key":"1430_CR9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.bmt.1705027","volume":"36","author":"E Kusumi","year":"2005","unstructured":"Kusumi E, Kami M, Kanda Y, Murashige N, Kishi Y, Suzuki R, et al. Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: a retrospective survey of 112 adult patients in Japan. Bone Marrow Transplant. 2005;36:205\u201313.","journal-title":"Bone Marrow Transplant"},{"key":"1430_CR10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/ajh.23246","volume":"87","author":"K Tada","year":"2012","unstructured":"Tada K, Kim SW, Asakura Y, Hiramoto N, Yakushijin K, Kurosawa S, et al. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma. Am J Hematol. 2012;87:770\u20135.","journal-title":"Am J Hematol"},{"key":"1430_CR11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12185-010-0608-7","volume":"92","author":"BD Cheson","year":"2010","unstructured":"Cheson BD. Targeted treatment and new agents in follicular lymphoma. Int J Hematol. 2010;92:5\u201311.","journal-title":"Int J Hematol"},{"key":"1430_CR12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF02982803","volume":"76","author":"AJ Grillo-Lopez","year":"2002","unstructured":"Grillo-Lopez AJ. Monoclonal antibody therapy for B-cell lymphoma. Int J Hematol. 2002;76:385\u201393.","journal-title":"Int J Hematol"},{"key":"1430_CR13","unstructured":"Swerdllow S, Campo E, Harris NL (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. France IARC (in press)."},{"key":"1430_CR14","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579\u201386.","journal-title":"J Clin Oncol"},{"key":"1430_CR15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/TP.0b013e318223d7ac","volume":"92","author":"N Uchida","year":"2011","unstructured":"Uchida N, Wake A, Nakano N, Ishiwata K, Takagi S, Tsuji M, et al. Mycophenolate and tacrolimus for graft-versus-host disease prophylaxis for elderly after cord blood transplantation: a matched pair comparison with tacrolimus alone. Transplantation. 2011;92:366\u201371.","journal-title":"Transplantation"},{"key":"1430_CR16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12185-012-1086-x","volume":"96","author":"K Minagawa","year":"2012","unstructured":"Minagawa K, Yamamori M, Katayama Y, Matsui T. Mycophenolate mofetil: fully utilizing its benefits for GvHD prophylaxis. Int J Hematol. 2012;96:10\u201325.","journal-title":"Int J Hematol"},{"key":"1430_CR17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295\u2013304.","journal-title":"Transplantation"},{"key":"1430_CR18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204\u201317.","journal-title":"Am J Med"},{"key":"1430_CR19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJM199303043280901","volume":"328","author":"NA Kernan","year":"1993","unstructured":"Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, et al. Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program. N Engl J Med. 1993;328:593\u2013602.","journal-title":"N Engl J Med"},{"key":"1430_CR20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695\u2013706.","journal-title":"Stat Med"},{"key":"1430_CR21","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1200\/JCO.1983.1.11.710","volume":"1","author":"JR Anderson","year":"1983","unstructured":"Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol. 1983;1:710\u20139.","journal-title":"J Clin Oncol"},{"key":"1430_CR22","first-page":"811","volume":"88","author":"Y Cohen","year":"2003","unstructured":"Cohen Y, Solal-Celigny P, Polliack A. Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance. Haematologica. 2003;88:811\u201323.","journal-title":"Haematologica"},{"key":"1430_CR23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12185-012-1202-y","volume":"96","author":"G Salles","year":"2012","unstructured":"Salles G, Ghesquieres H. Current and future management of follicular lymphoma. Int J Hematol. 2012;96:544\u201351.","journal-title":"Int J Hematol"},{"key":"1430_CR24","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1182\/blood-2012-03-417808","volume":"119","author":"IF Khouri","year":"2012","unstructured":"Khouri IF, Saliba RM, Erwin WD, Samuels BI, Korbling M, Medeiros LJ, et al. Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results. Blood. 2012;119:6373\u20138.","journal-title":"Blood"},{"key":"1430_CR25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbmt.2007.11.004","volume":"14","author":"P Hari","year":"2008","unstructured":"Hari P, Carreras J, Zhang MJ, Gale RP, Bolwell BJ, Bredeson CN, et al. Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning. Biol Blood Marrow Transplant. 2008;14:236\u201345.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1430_CR26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2141.2009.07905.x","volume":"147","author":"I Avivi","year":"2009","unstructured":"Avivi I, Montoto S, Canals C, Maertens J, Al-Ali H, Mufti GJ, et al. Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the lymphoma working party of the European Group for Blood and Marrow Transplantation. Br J Haematol. 2009;147:719\u201328.","journal-title":"Br J Haematol"},{"key":"1430_CR27","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.bbmt.2011.01.016","volume":"17","author":"T Shea","year":"2011","unstructured":"Shea T, Johnson J, Westervelt P, Farag S, McCarty J, Bashey A, et al. Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901. Biol Blood Marrow Transplant. 2011;17:1395\u2013403.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1430_CR28","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1200\/JCO.2009.26.9100","volume":"28","author":"KJ Thomson","year":"2010","unstructured":"Thomson KJ, Morris EC, Milligan D, Parker AN, Hunter AE, Cook G, et al. T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma. J Clin Oncol. 2010;28:3695\u2013700.","journal-title":"J Clin Oncol"},{"key":"1430_CR29","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3324\/haematol.2009.017608","volume":"95","author":"JL Pinana","year":"2010","unstructured":"Pinana JL, Martino R, Gayoso J, Sureda A, de la Serna J, Diez-Martin JL, et al. Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trials. Haematologica. 2010;95:1176\u201382.","journal-title":"Haematologica"},{"key":"1430_CR30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1200\/JCO.2007.11.5477","volume":"26","author":"AR Rezvani","year":"2008","unstructured":"Rezvani AR, Storer B, Maris M, Sorror ML, Agura E, Maziarz RT, et al. Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2008;26:211\u20137.","journal-title":"J Clin Oncol"},{"key":"1430_CR31","first-page":"1832","volume":"92","author":"K Besien van","year":"1998","unstructured":"van Besien K, Sobocinski KA, Rowlings PA, Murphy SC, Armitage JO, Bishop MR, et al. Allogeneic bone marrow transplantation for low-grade lymphoma. Blood. 1998;92:1832\u20136.","journal-title":"Blood"},{"key":"1430_CR32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/sj.bmt.1703891","volume":"31","author":"AJ Peniket","year":"2003","unstructured":"Peniket AJ, Ruiz de Elvira MC, Taghipour G, Cordonnier C, Gluckman E, de Witte T, et al. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transplant. 2003;31:667\u201378.","journal-title":"Bone Marrow Transplant"},{"key":"1430_CR33","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1182\/blood-2003-04-1205","volume":"102","author":"K Besien van","year":"2003","unstructured":"van Besien K, Loberiza FR Jr, Bajorunaite R, Armitage JO, Bashey A, Burns LJ, et al. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma. Blood. 2003;102:3521\u20139.","journal-title":"Blood"},{"key":"1430_CR34","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bbmt.2008.01.008","volume":"14","author":"P Armand","year":"2008","unstructured":"Armand P, Kim HT, Ho VT, Cutler CS, Koreth J, Antin JH, et al. Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome. Biol Blood Marrow Transplant. 2008;14:418\u201325.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1430_CR35","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1182\/blood.V73.6.1720.1720","volume":"73","author":"KM Sullivan","year":"1989","unstructured":"Sullivan KM, Weiden PL, Storb R, Witherspoon RP, Fefer A, Fisher L, et al. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood. 1989;73:1720\u20138.","journal-title":"Blood"},{"key":"1430_CR36","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood. 1990;75:555\u201362.","journal-title":"Blood"},{"key":"1430_CR37","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1182\/blood-2011-07-368233","volume":"119","author":"J Kanda","year":"2012","unstructured":"Kanda J, Hishizawa M, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y, et al. Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study. Blood. 2012;119:2141\u20138.","journal-title":"Blood"},{"key":"1430_CR38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/leu.2010.292","volume":"25","author":"J Delgado","year":"2011","unstructured":"Delgado J, Canals C, Attal M, Thomson K, Campos A, Martino R, et al. The role of in vivo T-cell depletion on reduced-intensity conditioning allogeneic stem cell transplantation from HLA-identical siblings in patients with follicular lymphoma. Leukemia. 2011;25:551\u20135.","journal-title":"Leukemia"},{"key":"1430_CR39","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3324\/haematol.10924","volume":"92","author":"S Vigouroux","year":"2007","unstructured":"Vigouroux S, Michallet M, Porcher R, Attal M, Ades L, Bernard M, et al. Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC). Haematologica. 2007;92:627\u201334.","journal-title":"Haematologica"},{"key":"1430_CR40","first-page":"e18511","volume":"29","author":"IF Khouri","year":"2011","unstructured":"Khouri IF, Saliba R, Korbling M, Alousi AM, Popat UR, Anderlini P, et al. Bendamustine in combination with fludarabine and rituximab: a novel nonmyeloablative conditioning for allogeneic stem cell transplantation (AST) in patients with lymphoid malignancies. ASCO Meet Abstr. 2011;29:e18511.","journal-title":"ASCO Meet Abstr"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-013-1430-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-013-1430-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-013-1430-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T03:07:36Z","timestamp":1596510456000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-013-1430-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,17]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["1430"],"URL":"https:\/\/doi.org\/10.1007\/s12185-013-1430-9","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,17]]}}}